Abstract:Rationale: STING is a critical player in the innate and adaptive immune system, sensing cytosolic DNA to activate the expression of interferon genes and regulate T lymphocytes, which drives immunogenic responses to cancer cells. Tumor-associated macrophages (TAMs), abundantly present in the tumor microenvironment, play a key role in cancer development. Gastric cancer is one of the most common and leading causes in cancer-related death worldwide. However, studies on the function and regulation of STING in TAMs and their roles in gastric cancer progression are still limited. Methods: We analyzed STING and CD68 expression of 200 pairs of gastric cancer and adjacent normal tissues by immunohistochemistry to identify the prognostic values of STING, as well as the correlations between STING and CD68 in gastric cancer. The characteristics of STING-altered macrophages, as well as their effects on cancer cell apoptosis and T cell differentiation were examined by flow cytometry. Cytokines secreted by STING-altered macrophages were identified by the Human Inflammation Array3 kit. Concentrations of soluble IL24 and IFN-β were measured by ELISA. In vivo models, including spontaneous gastric cancer in p53+/- mice and cell line-based xenografts, were established, and clinical benefits of STING-altered macrophages were examined. Results: Our study identifies STING as a prognostic factor for gastric cancer, and for the first time demonstrated that knocking-down STING and STING activation by 2'3'-c-GAMP both promote TAMs polarizing into pro-inflammatory subtype and induce apoptosis of gastric cancer cells, mechanistically through IL6R-JAK-IL24 pathway. Conclusions : This study evaluated effects of targeting STING in TAMs in anti-gastric-cancer therapies. Moreover, we unveil a novel function of STING to activate the IL6R-JAK-IL24 pathway in macrophages.

Cancer cell-extrinsic STING shapes immune-active microenvironment and predicts clinical outcome in gastric cancer

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer

An Analysis of the Expression and Association with Immune Cell Infiltration of the Cgas/sting Pathway in Pan-Cancer

Decreased Expression of STING Predicts Poor Prognosis in Patients with Gastric Cancer

Targeting the STING Pathway in Tumor-Associated Macrophages Regulates Innate Immune Sensing of Gastric Cancer Cells.

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling

Potential role of cGAS/STING pathway in regulating cancer progression

Epigenetic regulation of cGAS and STING expression in cancer

The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges

Role of micronucleus-activated cGAS-STING signaling in antitumor immunity

Erratum to Intercellular Transmission of Cgas-Sting Signaling in Cancer.

Cancer cell-autonomous cGAS-STING response confers drug resistance

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

Cellular functions of cGAS-STING signaling

Expanding the Role of STING in Cellular Homeostasis and Transformation

DNA sensing and immune responses in cancer therapy

Strategies involving STING pathway activation for cancer immunotherapy: mechanism and agonists